在非小细胞肺癌中,MAP1LC3C抑制降低了CIITA和HLAII类表达
Lydie M O Barbeau1, Nicky A Beelen2,3, Kim G Savelkouls1
1Department of Radiation Oncology (Maastro), GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.
PloS one
|February 10, 2025
概括
肺状细胞癌 (LUSC) 通过减少MAP1LC3C表达来逃避免疫攻击. 低MAP1LC3C阻碍免疫细胞的识别,影响免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 肺状细胞癌 (LUSC) 治疗已通过免疫检查点抑制剂 (ICI) 取得进展,约25%的患者受益.
- 挑战仍然存在,包括识别预测生物标志物和理解LUSC中的免疫抵抗机制.
- 瘤细胞可以成为"免疫感冒",逃避免疫检测和反应.
研究的目的:
- 研究微管相关蛋白1光链3 (MAP1LC3C) 在LUSC免疫逃避中的作用.
- 探索MAP1LC3C表达与免疫细胞透和抗原呈现机制之间的关系.
主要方法:
- 对LUSC.癌症基因组图谱 (TCGA) 数据集的分析.
- 在MAP1LC3C表达和免疫标记物 (CIITA,HLA) 之间的相关性分析.
- 在瘤细胞中对MAP1LC3C表达的实验操纵,以评估下游效应.
主要成果:
- 在LUSC瘤中观察到减少MAP1LC3C表达.
- 低MAP1LC3C与CIITA和HLAII类表达率下降相关.
- 在瘤细胞中抑制MAP1LC3C导致CIITA和HLAII类产量减少,免疫细胞透率降低.
结论:
- LUSC细胞可能会降低MAP1LC3C的调节,以逃避免疫监测.
- 低MAP1LC3C表达与抗原呈现减少和免疫细胞透有关.
- 准MAP1LC3C可能会增强LUSC的抗瘤免疫力.
更多相关视频
07:23Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
8.4K
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
7.3K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Co-activators and Co-repressors
7.2K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
